We developed a selective competitive enzyme-linked immunosorbent assay (ELISA) to monitor environmental and human exposure to polybrominated diphenyl ether BDE-47 that is used as a flame retardant. 2,2′,4,4′-Tetrabromodiphenyl ether (BDE-47), a dominant PBDE congener of toxicological concern, was the target analyte. To achieve effective hapten presentation on the carrier protein for antibody production, immunizing haptens with a rigid double-bonded hydrocarbon linker introduced at different positions on the target molecule were synthesized as well as coating haptens that mimic a characteristic fragment of the molecule. Rabbit antisera produced against each immunizing antigen were screened against competitive hapten coating antigens. Under optimized competitive indirect ELISA conditions, the linear detection range in the assay buffer that includes 50% dimethyl sulfoxide was 0.35-8.50 µg/L with an IC 50 value of 1.75 µg/L for BDE-47. Little or no crossreactivity (<6%) was observed to related PBDE congeners containing the BDE-47 moiety and other halogenated compounds. Using a magnetic particle-based competitive direct ELISA increased the sensitivity by 10-fold over the indirect ELISA. The ELISA provided quantitative results when performed on small volume/weight samples such as dust, furniture foam, and blood/ serum following sample preparation, suggesting a convenient screening tool.
Introduction
Polybrominated diphenyl ethers (PBDEs) are flame retardants that are added into consumer products. PBDEs in those products contain predominantly penta-(also including tetra-), octa-, and decaBDE congeners. The U.S. market used about 8000 t in 1999, which is about 98% of the global production of pentaBDE (1). PentaBDEs were used in polyurethane foam in furniture and some building materials, whereas BDE-209 was used in electronic plastic products (2), and fabric-back coatings. The concentrations of other polyhalogenated chemicals such as polychlorinated biphenyls (PCBs), polychlorinated dibenzop-dioxin (PCDDs), polychlorinated dibenzofurans (PCDFs), and DDT (3) are declining as a result of reduction policies, whereas PBDEs in the environment are rapidly rising worldwide (4). PBDEs accumulate in house dust, sewage sludge, biosolids, wildlife/pets, and humans (5-9); especially BDE-47 and BDE-99 accumulate to a greater degree than the higher halogenated BDEs (1, 10). The PBDE levels of North Americans are among the highest in the world (6). Aside from workers in electronic-recycling facilities that experience high PBDE exposure (11), a major route of exposure to PBDEs is ingestion of indoor dusts (12).
PBDEs exhibit a wide spectrum of toxicity in laboratory animals, primarily developmental and neurological in nature (13, 14) . PBDEs are also structurally similar to thyroid hormones and may act as endocrine disruptors by altering thyroid hormone function (15, 16) , thus there is increasing concern for women of childbearing age.
Analytical methods for detection of PBDEs in biological samples such as milk and adipose tissues use sample preparation steps including solvent extraction, liquid-liquid extraction, and column chromatographic cleanup methods combined with gas chromatography and electron capture detection (GC-ECD) or GC with mass spectrometry (GC-MS) (17, 18) . Although sensitive, the methods are time-consuming and expensive. An X-ray fluorescence (XRF) analyzer measures total bromine levels of brominated flame retardants present in consumer products nondestructively and in real time (19) . Alternatively, immunoassays are rapid, sensitive, and selective analytical tools that have been used to determine trace chemicals of interest such as agrochemicals and their degradation products (21-23) and industrial contaminants such as PCBs, dioxins, and nonylphenol (20, [24] [25] [26] [27] . Use of an immunoassay would provide more selective detection of PBDEs than XRF, and it is less time-consuming than typical instrumental methods.
Because of its abundance and toxicity, BDE-47 can be an indicator of exposure to lower brominated PBDEs and so was selected as the target for immunoassay development. Shelver et al. (28) developed a heterologous competitive indirect immunoassay using a rabbit antiserum generated against an immunizing hapten synthesized by introducing a butyric acid spacer to 5-hydroxy-BDE-47. It detected both BDE-47 and BDE-99 and was later developed into a magnetic particle-based immunoassay (29). Generally it is more difficult to develop an assay for lipophilic than polar compounds. However, we have taken several approaches to successfully develop selective assays for compounds such as dioxins and pyrethroid insecticides (26, 30) . On the basis of this experience, an immunoassay for PBDEs was developed, optimized, characterized, and applied to diverse matrices including furniture foam, house dust, and whole blood/serum using sample sizes as low as 10 µL or 10 mg.
Experimental Section
Chemicals and Instruments. The hapten coupling reagents, bovine serum albumin (BSA), keyhole limpet hemocyanin (KLH), goat antirabbit IgG peroxidase conjugate (GAR-HRP), Tween 20, and 3,3′,5,5′-tetramethylbenzidine (TMB) were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO). Horseradish peroxidase (HRP) was purchased from Thermo Fisher Scientific Inc. (Rockford, IL) . ELISA was performed on 96-well microtiter plates (Nunc MaxiSorp, Roskilde, Denmark) and read spectrophotometrically with a microplate reader (Molecular Devices, Sunnyvale, CA) in dual wavelength mode (450-650 nm) .
Hapten Synthesis. Because BDE-47 is of small molecular weight, it requires conjugation to carrier proteins to be immunogenic. BDE-47 and its analogs (haptens) containing a carboxylic acid group were designed (Supporting Information (SI), Figure S1 ) and synthesized ( Figure 1 ). The main reactions to prepare haptens containing a brominated diphenyl ether moiety and a double-bonded hydrocarbon linker were based on methods previously described (26, 31, 32) . The synthesis is detailed in the SI.
Preparation of Immunogen and Coating Antigens. Haptens containing carboxylic acids were activated by the mixed anhydride method (26) or the carbodiimide method (33). For immunogens, type A-C haptens ( Figure 1 ) were conjugated to KLH. Type A-D haptens were conjugated to BSA for coating antigens. For the magnetic particle-based ELISA, hapten D3 was coupled to HRP by the carbodiimide method (33). Complete details may be found in the SI.
Immunization and Antiserum Preparation. The immunization procedure followed the protocol reported previously (33, 34) . Two female New Zealand white rabbits were immunized for each immunogen (Rabbits 1304/1305, Hapten A2-KLH; Rabbits 1306/1307, Hapten A1-KLH; Rabbits 1308/ 1309, Hapten B2-KLH; Rabbits 1310/1311, Hapten B1-KLH; Rabbits 1312/1313, Hapten C1-KLH; and Rabbits 1314/1315, Hapten C2-KLH). Final serum was collected 5 months following the first immunization. Antiserum was obtained by centrifugation, stored at -80°C, and used without purification.
Competitive Indirect ELISA. The preparation of the buffers and the procedure for the indirect competitive ELISA have been previously described (33). We typically use the indirect method because it is more conservative of haptens that are in short supply from complex synthetic methods; we have found hapten-BSA conjugates to be more stable than hapten-enzyme conjugates, and the indirect method is less susceptible to matrix effects. The IC 50 value, an expression of the sensitivity of immunoassay, and the limit of detection (LOD) defined as the IC 10 value were obtained from a four-parameter logistic equation. Borosilicate glass tubes were used to prepare standard and sample solutions to minimize the surface adsorption of BDE-47.
Immunological Analysis of Industrial, Environmental, and Biological Samples. Specific details are found in the SI.
House Dust. Dust from the vacuum cleaner bag collected from single family homes in Northern California was sieved to 150 µm with a stainless steel screen. A 100 mg dust sample was extracted using microwave-assisted solvent extraction (35) . The hexane layer was collected and washed with concentrated H 2 SO 4 , then deionized water, and dried with anhydrous Na 2 SO 4 . After evaporation the extract was redissolved in DMSO, then diluted 2-16 times prior to the immunoassay. Each sample (n ) 17) was analyzed in triplicate. Because PBDE-free dusts were not available for the recovery study, a Standard Reference Material 2585 house dust (National Institute of Standards and Technology, Gaithersburg, MD) having a certified value of 497 ( 46 µg/kg of BDE-47 was tested.
Furniture Foam. Polyurethane foam samples (∼10 mg) obtained from houses and local furniture stores were shaken with DMSO on an orbital shaker (Lab-line, Melrose Park, IL) for 24 h at room temperature. An aliquot of the DMSO extract was diluted 400-6400 times prior to the immunoassay. Each sample was analyzed in triplicate. For the recovery study, 10 mg of furniture foam that did not contain brominated flame retardants as measured by XRF was spiked at 0.1-3% BDE-47 and extracted as described above. Each sample (n ) 13) was analyzed in triplicate. Results are expressed as percent since levels of PBDEs are added to furniture foam in amounts of 3-6%.
Human Whole Blood/Serum. Calf serum (Invitrogen, Carlsbad, CA) was denatured as previously described (36) . BDE-47 was extracted by liquid-liquid extraction (LLE) with CH 2 Cl 2 in hexane. Concentrated H 2 SO 4 was added to the extract to remove lipids. The organic layer was washed with NaOH followed by distilled water, then dehydrated through anhydrous Na 2 SO 4 and evaporated. The residue was reconstituted with 50% DMSO in PBST. For the recovery study, BDE-47 was spiked at 1-5 ng/mL into 0.5 mL of calf serum. The samples were extracted as described above and analyzed in triplicate.
Human whole blood (10 µL) or a commercial human serum (Sigma, Milwaukee, WI) was mixed with distilled water, extracted with ethyl acetate, evaporated to dryness, and dissolved in 50 µL of DMSO, followed by addition of 50 µL of PBS prior to the immunoassay. Final dilution was 10-fold in the assay buffer. For the recovery study, BDE-47 dissolved in acetone was spiked at 10-100 ng/mL into 10 µL of the calf serum or whole blood. The samples were extracted as described above and analyzed in triplicate.
GC/MS Analysis of Dust. Dust samples (0.1 or 0.5 g) were spiked with surrogate recovery standards (SRSs; 25 ng each of BDE-126 and 13 C 12 BDE-209), extracted in 1:1 hexane/ CH 2 Cl 2 by ultrasonication, and cleaned up using bulk acidic silica and an alumina SPE cartridge. Extracts were analyzed using GC/MS with methane negative ion chemical ionization (Agilent/HP 6890 GC and 5973 MSD). The chromatography included separation on a DB-5 ms column. BDE-47 was quantified using the internal standard method (dibromobiphenyl as the internal standard). SRS recoveries were 102 ( 23% for BDE-126 and 93 ( 28% for 13 C 12 BDE-209. Spiked recoveries of BDEs in one representative house dust ranged from 78 to 109%. The average relative percent difference in replicate samples was less than 24%.
XRF Analysis of Furniture Foam. A portable hand-held XRF analyzer (Innov-X Systems, Inc., Woburn, MA) was used to measure total bromine concentration in furniture foam samples. The analyzer was held against a large piece of foam in a couch cushion in situ. Each sample had one reading at 50 s per reading. Standard reading times are 30 s as recommended by the manufacturer. The extended measuring time was used for accurate data acquisition without repetition. A sample of at least 1 in.
2 was then removed from each product for further ELISA testing. Although the sample was not taken from exactly the same site as the XRF reading, multiple XRF readings from the same foam cushion showed good agreement (data not shown). A limit of detection was set conservatively at 0.1% (w/w). The XRF results were compared with ELISA measurements. Although XRF cannot distinguish the chemical form of the bromine, we utilized the XRF method for comparisons because it is being used for on site assessment of flame retardants in furniture foam. Gas chromatographic methods were not performed for this study.
Results and Discussion
Hapten Synthesis. Since synthesis and production of antibodies is time-and cost-consuming, the hapten chemistry should be thoroughly researched to develop the most sensitive and selective immunoassay (20, 37) . BDE-47 is of small molecular weight and requires conjugation to carrier proteins to be immunogenic. Antibodies are generally formed to the part of the molecule that is most distal to the point of attachment to the carrier protein. Potential haptens with a functional group (-COOH) for conjugation were designed ( Figure S1 ). We prepared haptens that mimic the whole BDE-47 molecule and contained a rigid linker with at least one double-bonded hydrocarbon and a carboxylic reactive group so that the hapten would extend from the surface of the carrier-protein during antibody formation. The number of carbons in the linker ranged between 1 and 5 and the linkers were attached at the 2′ (Type A), 4′ (Type B), or 5′ (Type C) position of the BDE-47 molecule to expose different parts of the PBDE molecule for antibody recognition. Due to the lipophilicity of PBDEs, a long side chain could allow the lipophilic hapten to fold back into the hydrophobic interior of the carrier protein and decrease the affinity of the resulting antibodies. A rigid linker, such as a carbon chain with one or more double bonds, can generate sensitive and selective antibodies for lipophilic molecules like dioxins (26). A rigid spacer was introduced into dibromophenoxy-bromobenzaldehyde (compound 1) by enylation with phosphonoacetate or phosphonocrotonate using LiOH and molecular sieve by the Wittig or Horner-Wadsworth-Emmons reaction (Figure 1, (32) ). The aldehyde intermediates were oxidized by Ag 2 O to obtain acid haptens A3 and B3. In contrast to haptens type A-C, type D haptens that only mimic the dibromophenoxy were designed as coating antigens to enhance the affinity of BDE-47 to the antibody and to increase assay sensitivity. The haptens were synthesized to obtain different lengths of a single-bonded hydrocarbon linker on a phenyl or pyridine ring. Ethyl bromobutyrate or ethyl bromohexanoate was used for the carbon linker attachment on the dibromophenol or 3,5-dibromo-2-hydroxypyridine.
Antibody Characterization. The antisera collected after each boost were subjected to titration by the homologous indirect ELISA. All of the antisera showed relatively constant high titers after the fifth immunization (data not shown) and no significant affinity for BSA alone. All 12 antisera were screened against 9 coating antigens at the 2 concentrations (5 and 500 µg/L) of BDE-47 (data not shown). The combinations of antibody and coating antigen that had over 80% inhibition at 500 µg/L and with over 20% inhibition at 5 µg/ L, were again screened using 10 concentrations ranging from 0.003 to 5000 µg/L. The antisera against hapten type A consistently had the highest IC 50 s, while antisera against hapten type C had mixed results depending upon the coating antigen used. The antisera with the lowest IC 50 were mainly raised against immunizing hapten B2 and B1 (Table S1 ), suggesting that these immunizing haptens containing a double-bonded carbon linker at the 4′-position are the closest mimics of BDE-47 among the synthesized haptens. Antibody 1309 generated against the immunizing hapten B2 was selected for further immunoassay development due to both high maximum signals and low IC 50 values.
Molecular Modeling. Structural modeling of haptens is a useful tool to select haptens that best mimic the target.
Since PBDEs including BDE-47 have a noncoplanar conformation and exist in a twist between the two phenyl moieties (38) , the hapten with the same molecular geometry as that of BDE-47 is desired to produce specific antibodies. After the optimization of the molecular geometry of haptens and other PBDE congeners, their molecular geometries were overlaid on that of BDE-47. The order of rms values, which indicate the error in molecular geometry between the structures tested and BDE-47, is as follows: hapten C1 > hapten C2 > hapten C3 > hapten A1 > hapten B3 > BDE-153 > hapten A3 > hapten A2 > BDE-99 > hapten B2 > hapten B1 > BDE-47 (Table S2) . Because the rms values of haptens B1 (rms ) 0.0475) and B2 (rms ) 0.0832) are closest to that of BDE-47 (rms ) 0.0000), the antibodies generated against them provided relatively highly sensitive assays (Table S1 ). Antibody 1309 was generated against hapten B2 which was the optimal hapten via molecular modeling. Although hapten A3 containing a short spacer also had a low rms value (0.2188), haptens with longer (C-3 to -5) carbon linker were selected as immunizing haptens. Haptens with a short spacer (C-1; rms ) 1.3871) may not provide maximum presentation of the unique structural features of the analyte to the immune system, because of steric hindrance.
Enhancement of Assay Sensitivity using Heterologous Coating Haptens. As shown in Table S3 , heterologous formats were far more sensitive than the homologous one. The highest sensitivity is obtained when the binding affinity of the antibody to the target analyte is much stronger than to the coating antigen. The heterologous coating hapten C3, which imitates the whole structure of the BDE-47, but presents different molecular geometry, showed more sensitivity than the homologous coating hapten. The type D haptens that imitate one ring of BDE-47 provided more sensitivity than the whole structure mimic hapten C3. The longer spacer of coating hapten D2 than hapten D1 exhibited better assay sensitivity. Finally, a pyridine-like coating hapten D3 with the same length of linker as hapten D2 provided the most sensitive assay. Due to the contribution of the extra electron cloud of N in the ring, D3 is more structurally different from the immunizing hapten mimicking BDE-47, and thus decreases the affinity to antibody 1309 and increases the assay sensitivity remarkably.
Assay Optimization. The optimum concentrations of coating antigen hapten D3-BSA and Ab 1309 were 5 µg/mL and 1:8000 dilution in the well, respectively. Since BDE-47 is highly lipophilic and adsorbs to glass, plastic, or other particle surfaces, a cosolvent is important for consistent assay performance and sensitivity. Use of DMSO decreased background and increased sensitivity compared to 40% methanol in PBST. DMSO (50%) was selected to prepare standard or sample solutions due to the low IC 50 value (1.8 µg/L) and maximum A/D ratio (Table S4 ). The IC 50 value was not affected by higher ionic strength, although a decrease in A max indicated that the binding interaction of antibody to antigen was affected. There were no significant effects of pH ranging from 6.5 to 9.5 in the buffer on the IC 50 value, but, the maximum absorbances were variable at low concentrations of BDE-47 with all pHs tested (data not shown). Thus, the pH of PBS was maintained at 7.5. Ab 1309 was diluted in 0.2% BSA in PBS. Finally, the optimized ELISA used hapten D3-BSA coating antigen at a concentration of 5 µg/mL and Ab 1309 produced against hapten B2-KLH at a dilution of 1/8000 in wells. The coated plate was blocked with 0.5% BSA. The assay buffer was 50% DMSO in 0.15 M PBS, pH 7.5. This heterologous assay had a linear range (IC 20-80 ) of 0. 35-8.50 µg/L in the buffer system and an IC 50 value of 1.75 µg/L ( Figure S3 ). The LOD in the buffer was defined as 0.2 µg/L, the IC 10 value.
Magnetic Particle-Based ELISA. To improve speed and sensitivity, we developed an IgG magnetic particle-based competitive direct ELISA. Although this initial assay is currently characterized by high background (likely due to nonspecific binding of the hapten D3-HRP conjugate to the magnetic particles possessing relatively larger surface areas), compared with the coating antigen ELISA using a 96-well plate, this ELISA was 10-fold more sensitive ( Figure S3 ). This increased sensitivity may result from a relatively well-oriented antibody on the enlarged surface area of the goat antirabbit The values of house dust and furniture foam were average values of data calculated from 2-, 4-, 8-, and 16-fold dilution factor of the extract, and from 800-, 1600-, and 3200-fold dilution factor, respectively.
IgG magnetic particles as well as from using a direct competitive hapten D3-HRP conjugate. Dispersive magnetic particle-based technology facilitates the separation of the desired immunocomplex in solution and can be easily automated (22) . Although this direct competitive format is more sensitive, it was not further investigated because it used large quantities of antibody compared to the plate assay and high throughput was not necessary for this study.
Cross-Reactivity (CR). Various compounds structurally related to BDE-47 were evaluated for CR. The assay was highly selective for BDE-47, showing very low CRs (<6%) to other PBDEs congeners including BDE-49, having the same number of Br atoms as BDE-47 (Table S5 ). The antibody binding pocket generated against a hapten containing a low number of bromines may preclude the binding of larger PBDEs containing more bromine substitutions. Although the rms value of BDE-99 is close to those of BDE-47 and hapten-B2 (Table S2) , the low CR (5%) indicates that the antibody produced binds less to BDE-99, likely due to differences in electrostatic potentials and steric hindrance caused by having five Br atoms. Little or no cross-reactivity was seen to other related halogenated compounds such as PCB, dioxin, dihalophenols, and triclosan. 3-Methoxy-BDE-47 showed relatively high CR (35%) among metabolites of BDE-47.
Matrix Effects. The standard curves in spiked calf serum and furniture foam samples were parallel to those of the BDE-47 standard curve prepared in assay buffer ( Figure S2A and B) indicating no matrix effect. This clearly demonstrates the efficacy of each sample preparation method in removing interfering components resulting in quantitative measurement of BDE-47. Recoveries were 82-138% in serum/blood samples, 71-130% in furniture foam samples, and 105% in a certified house dust sample.
House dust is a complex mixture of biologically derived materials such as animal dander, fungal spores, dead skin cells, dirt, and mineral particles deposited from outdoors. A cleanup that used an alkaline (NaOH) solution during the microwave-assisted hexane extraction followed by a H 2 SO 4 cleanup of the hexane extract provided results comparable to GC/MSD analysis for house dust (Table 1) . This cleanup process can be simplified for high throughput using a multilayer silica gel treated with H 2 SO 4 and NaOH.
Sulfuric acid treatment removed lipophilic residues coextracted by the CH 2 Cl 2 /hexane mixture in serum improving the assay to as low as 1 µg/L (Table S6) . However, the LLE method using 10-µL sample is a simple method for crude screening of BDE-47 in the blood/serum or milk as demonstrated by the good recoveries seen for human whole blood. The small sample volume (10 µL) and simple sample preparation coupled to the sensitive ELISA can provide relatively high-throughput analysis in 96-well plates. It may be feasible to develop miniaturized tools for sample preparation and apply those to automated analysis.
DMSO extraction of furniture foam using a 10-mg sample and dilution provided suitable monitoring for BDE-47. Although pentaBDE is currently banned in many but not all countries, this ELISA can be used to screen their occurrence in consumer products still in use.
Validation for Application to Real Samples. A relatively good correlation for selected house dust samples was exhibited between GC/MS data and ELISA (Table 1) . The concentrations of BDE-47 equivalent in the dust samples, V and VI, determined by the ELISA were around 1.6-1.9 times higher than those determined by the instrumental analysis. Similarly, as shown in Figure 2A , there is a positive correlation (r 2 ) 0.78) between BDE-47 data in a representative collection of dust samples that includes the samples in Table 1 measured by the ELISA and GC/MS. The immunochemical method overestimated the occurrence of BDE-47 compared to GC/ MS. This higher concentration could result from other unidentified cross-reacting compounds and/or a nonspecific interference from this dust matrix. Although BDE-99 cross reacts at 6%, a mixture having a 5-fold higher concentration of BDE-99 than BDE-47 in a solution did not effect the ELISA response for the detection of BDE-47 nor did an equal concentration mixture of BDE-47, -99, and -153 (data not shown). For dust analysis, this ELISA may best be used as a screening tool or to rank samples for instrumental analysis.
There was a moderate correlation (r 2 ) 0.38) between the concentration of BDE-47 equivalent in furniture foams measured by the ELISA and the total bromine occurrence measured by XRF ( Figure 2B ). This is not surprising since the ELISA selectively detects BDE-47 while the XRF is measuring total bromine that may be present from the use of other brominated flame retardants (39) . The validation for application of this ELISA to real samples (total n ) 17) was achieved in diverse sample matrices including serum, whole blood, house dust, and furniture foam in a wide range of concentrations, which were spiked with BDE-47. The linear regression of the results showed a highly positive correlation (r 2 ) 0.998) with a slope of 0.75 ( Figure 2C ).
In conclusion, to develop a selective immunoassay for BDE-47, the introduction of a rigid double-bonded hydro- carbon spacer in a near perfect molecular mimic of BDE-47 aids in the recognition of the BDE-47 hapten while an antibody is generated. A heterologous coating hapten having a brominated pyridine moiety that influences the affinity of the antibody for the analyte in the competitive assay results in the highest sensitivity assay. The two immunoassay formats developed for PBDEs are highly sensitive with IC 50 values of 1.75 µg/L for BDE-47 in a competitive indirect format and 0.1 µg/L in a competitive direct format. Concentrated sulfuric acid treatment and a hexane extraction that removes interfering lipid materials were used as a common sample preparation method prior to the immunoassay providing quantitative measurement in serum and dust. Additionally, this immunoassay, using sample sizes as low as 10 µL or 10 mg can be adapted for relatively high-throughput analysis.
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Instruments.
1 H-Nuclear magnetic resonance (NMR) spectra of compounds synthesized were obtained on a General
Electric QE-300 spectrometer (Bruker NMR, Billerica, ME) using tetramethylsilane as an internal standard. Electrospray Nomenclature. The nomenclature of haptens was designated with the aid of Chemdraw Ultra 9.0 (CambridgeSoft, Cambridge, MA).
Synthetic Procedures
BDE-47. BDE-47 as the target analyte was synthesized in the laboratory according to a method reported previously (Noguchi et al., 1978) and purified by recrystallization from methanol, and a mixture of ethyl acetate and methanol (purity
>99.8% (GC)).

Type A Haptens:
Synthesis of (2E,4E)-5-(5-bromo-2-(2,4-dibromophenoxy)phenyl)penta-2,4-dienoic acid (hapten A1):
To a solution of 5-bromo-2-(2,4-dibromophenoxy)benzaldehyde (compound 1, 500 mg, 1.16 mmol) prepared according to a method published previously (Marsh et al., 2008) and triethyl 4-phosphonocrotonate (321 mg, 1.28 mmol) in dry tetrahydrofuran (THF, 10 mL) was added LiOH . H 2 O (42 mg, 1.28 mmol) and molecular sieve 4 Å (2 g). The mixture was refluxed overnight under N 2 conditions. Ethyl acetate (50 mL), water (50 mL) and NaCl (1 g) were added and the organic layer was separated. After removing the organic solvent, the crude residues were purified by silica gel chromatography using a mixture of ethyl acetate and hexane (1:15, v/v) to give (2E,4E)-ethyl 5-(5-bromo-2-(2,4-dibromophenoxy)phenyl)penta- 
Synthesis of (E)-3-(5-bromo-2-(2,4-dibromophenoxy)phenyl)acrylic acid (hapten A2):
To dry THF (2 mL) were added triethyl 2-phosphonoacetate (120.12 mg, 0.50 mmol) and 60% sodium hydride in oil (28 mg 1 g) and the mixture was refluxed overnight under N 2 conditions. Ethyl acetate (50 mL), water (50 mL) and NaCl (1 g) were added and the organic layer was separated. The crude residues were purified by silica gel chromatography using a mixture of ethyl acetate and hexane 
Synthesis of (E)-3-(3-bromo-4-(2,4-dibromophenoxy)phenyl)acrylic acid (hapten B2):
To dry THF (1 mL) were added triethyl phosphonoacetate (120.12 mg, 0.50 mmol) and 60% sodium hydride in oil (28 mg 
Synthesis of 3-bromo-4-(2,4-dibromophenoxy)benzoic acid (hapten B3): As described for hapten A3, hapten B3
from 3-bromo-4-(2,4-dibromophenoxy)benzaldehyde (compound 4) was prepared to give a white solid (15 mg, yield: To a solution of compound 8 (50 mg, 0.14 mmol) in 3 mL of 4-dimethylaminopyridine (DMAP), potassium carbonate (0.28 mmol, 38.7 mg), and 18-crown-6 (0.028 mmol, 7.4 mg) was added 2,2',4,4'-tetrabromodiphenyl iodonium chloride (compound 9, 88 mg, 0.14 mmol ) synthesized according to a method published previously (Marsh et al., 2003) and the reaction mixture was refluxed at 80 °C for 4 h. Ethyl acetate (50 mL × 2) and water (50 mL) were added to the reaction mixture. The combined organic layers were dehydrated over anhydrous sodium sulfate and concentrated. The crude product was purified by silica gel chromatography with a mixture of ethyl acetate and hexane ( (M + +8).
As described for hapten A1, hapten C1 from the ester compound 10 was prepared to give a white solid (20 mg, yield: 
Synthesis of (E)-3-(2,4-dibromo-5-(2,4-dibromophenoxy)phenyl)-2-methylacrylic acid (hapten C2):
To a solution of sodium hydride (99.2 mg, 2.48mmol) in 5 mL of THF cooled to 0 o C, triethyl 2-phosphonopropionate (432.37 mg, 1.82 mmol) was added dropwise. The mixture was stirred for 1 h at room temperature. The compound 7 was added at 0 o C.
After stirring for 2 d, the solution was quenched with aqueous ammonium chloride. The mixture was extracted by ethyl acetate and brine. The organic layer was evaporated. The residue was purified by silica gel chromatography using a mixture of ethyl acetate and hexane (1:9, v/v). The fractions containing (E)-ethyl 3-(2,4-dibromo-5-hydroxyphenyl)-2-methylacrylate (compound 11) were recrystallized from ethyl acetate and hexane to give white crystals (70 mg, yield: 
To a solution of the compound 11 (50 mg, 0.14 mmol) in 3 mL of DMAP, potassium carbonate (38.7 mg, 0.28 mmol), and 18-crown-6 (7.4 mg, 0.028 mmol) was added the compound 9 (88 mg, 0.14 mmol) and the reaction mixture was refluxed at 80 °C for 3 h. Ethyl acetate (50 mL × 2) and water (50 mL) were added to the reaction mixture. The combined organic layers were dehydrated over anhydrous sodium sulfate. The crude product was purified by silica gel chromatography with a mixture of ethyl acetate and hexane (1:15, v/v) to give an oil residue (64 mg, yield: 77%) of (E)- Synthesis of (2E,4E)-5-(2,4-dibromo-5-(2,4-dibromophenoxy)phenyl)penta-2,4-dienoic acid (hapten C3): To a solution of the compound 7 (699.8 mg, 2.5 mmol) and NaOH (120 mg, 3 mmol) in water (15 mL) and dioxane (15 mL) was added the compound 9 (1882.77 mg, 3 mmol) and the reaction mixture was refluxed overnight. Water (50 mL) and ethyl acetate (50 mL) were added to the mixture. The organic layer was separated, washed with 1 N NaOH (30 mL) and washed with water (30 mL). The separated organic layer was evaporated and purified by silica gel chromatography using a mixture of ethyl acetate and hexane (1:15, v/v) to give 2,4-dibromo-5-(2,4-dibromophenoxy)benzaldehyde (compound 
Haptens in Type D:
Synthesis of 4-(2,4-dibromophenoxy)butanoic acid (Hapten D1): The mixture of the 2,4-dibromophenol (300 mg, 1.2 mmol), ethyl 4-bromobutyrate (308.19 mg, 1.58 mmol), and anhydrous potassium carbonate (207 mg, 1.58 mmol) in 1 mL of anhydrous DMF was reacted at 100 o C for 5 h. The resulting mixture was filtered to remove excess K 2 CO 3 and HBr produced in the reaction. The filtrate diluted with 20 mL of ethyl acetate was washed twice with 20 mL of distilled water.
The organic layer was dried over anhydrous sodium sulfate and the solvent was removed by evaporation. The residue was chromatographed on silica gel eluting with a mixture of ethyl acetate/hexane (1:20, v/v 
Preparation of Immunogen and Coating Antigens.
Haptens containing carboxylic acids were activated by the mixed anhydride method or the carbodiimide method. For immunogens, Type A-C haptens were conjugated to keyhole limpet hemocyanin (KLH). Type A-D haptens were conjugated to bovine serum albumin (BSA) for coating antigens. The mixed anhydride conjugation of hapten (0.03 mmol)
to each protein (20 mg) was described previously (Sanborn et al., 1998) . For the N-hydroxysuccinimide (NHS) method, hapten (0.04 mmol), dissolved in 1 mL of dry dimethylformamide (DMF) with NHS (0.048 mmol) and N,N'-dicyclohexylcarbodiimide (DCC, 0.048 mmol) was conjugated to BSA (25 mg) as previously described (Lee et al., 2002) .
Note that direct coupling with a water soluble carbodiimide can result in immunogenic urea-protein adducts.
For the magnetic particle-based ELISA, hapten D3 (4 mg) was dissolved in 2 mL of dry DMF with NHS (1.38 mg) and DCC (2.76 mg), and activated to an ester intermediate. An aliquot corresponding to a 20-fold molar excess over protein of the resulting ester was added slowly to a solution of 2 mg HRP in 3 mL of 0.13M NaHCO 3 (pH 8.5). The mixture was stirred gently at 4 °C for 30 min, followed by dialysis against PBS for 3 days.
Immunological Analysis of Industrial, Environmental, and Biological Samples.
House Dust. Dust from the vacuum cleaner bag collected from single family homes in Northern California was sieved to 150 µm with a stainless steel screen. A 100 mg dust sample was extracted using microwave-assisted solvent extraction Human Whole Blood/Serum. Calf serum (Invitrogen, Carlsbad, CA) was denatured as previously described . BDE-47 was extracted by liquid-liquid extraction (LLE) with CH 2 Cl 2 in hexane. Concentrated H 2 SO 4 was added to the extract to remove lipids. The organic layer was washed with NaOH followed by distilled water, then dehydrated through anhydrous Na 2 SO 4 and evaporated. The residue was reconstituted with 50% DMSO in PBST. For the recovery study, BDE-47 was spiked at 1-5 ng/mL into 0.5 mL of calf serum. The samples were extracted as described above and analyzed in triplicate.
Human whole blood (10 µL) or a commercial human serum (Sigma, Milwaukee, WI) was mixed with distilled water, extracted with ethyl acetate, evaporated to dryness, and dissolved in 50 µL of DMSO, followed by addition of 50 µL of PBS prior to the immunoassay. Final dilution was 10-fold in the assay buffer. For the recovery study, BDE-47 dissolved in acetone was spiked at 10-100 ng/mL into 10 µL of the calf serum or whole blood. The samples were extracted as described above and analyzed in triplicate. 
GC/MS
